Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigen

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1474-1477

  Tseng, Kuo Chih ^a   Lei, Huan Yao ^c   Cheng, Pin Nan ^b   Young, Kung Chia ^c   Jen, Chung Min ^b,c   Wu, Chao Hsien ^b   Chang, Ting Tsung ^b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Anamnestic response; Isolated anti HBc; Primary response; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; MEMBRANE ANTIGEN;

ADULT; ANTIBODY ISOLATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HEPATITIS B; HOSPITAL PERSONNEL; HUMAN; IMMUNE RESPONSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VACCINATION;

ADULT; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; MALE; RADIOIMMUNOASSAY; VIRAL HEPATITIS VACCINES;

EID: 0141540415     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mushahwar IK, Dienstag JL, Polesky HF, McGrath LC, Decker RH, Overby LR: Interpretation of various serological profiles of hepatitis B virus infection. Am J Clin Pathol 1981; 76:773-777.
2. Lee SD, Lo KJ, Tsai YT, Wang JY, Lai KH, Wu JC, et al: Hepatitis B vaccination in healthy Chinese adults with low dose regimens. Vaccine 1987; 5:195-198.
3. Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, et al: Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs. J Formos Med Assoc 1980; 79:760-767.
4. Wang SS, Yeh CL, Tsai YT, Lee SD, Lai KH, Lo KJ: Occupational exposure to hepatitis B virus among hospital personnel. J Formos Med Assoc 1985; 84:810-816.
5. Chan CY, Lee SD, Tsai YT, Lo KJ: Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J of Gastroenterol Hepatol 1995; 10:192-197.
6. Hu M, Schenzle D, Deinhardt F, Scheid R: Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers. Am J Epidemiol 1984: 120:404-413.
7. Chiaramonte M, Fabris P, Bertin T, Trivello R, Renzulli G, Mocellin C, et al: Response to hepatitis B vaccine in subjects with isolated antiHBs or antiHBc. Hepatology 1988; 8:1409A.
8. Kitchen AD, Harrison TJ, Meacock TJ, Zuckerman AJ, Harrison JF: Incidence and significance of hepatitis B core antibody in a healthy blood donor population. J Med Virol 1988; 25:69-75.
9. Schifman RB, Rivers SL, Sampliner RE, Krammes JE: Significance of isolated hepatitis B core antibody in blood donors. Arch Intern Med 1993; 153:2261-2266.
10. Tong MJ, Howard AM, Schatz GC, Kane MA, Roskamp DA, Co RL, et al: A hepatitis B vaccination program in a community teaching hospital. Infect Control 1987; 8:102-107.
11. McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP, et al: A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet 1987; 8568:1134-1136.
12. Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S: Response to hepatitis B vaccine in HBsAg / anti-HBs negative and anti-HBc positive subjects. Scand J Infect Dis 2000; 32:315-316.
13. Luo KX, Zhou R, He C, Liang ZS, Jiang S: Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to hepatitis B core antigen. J Med Virol 1991; 35:55-59.
14. Lok ASF, Lai CL, Wu PC: Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988; 8:766-770.
15. Feret E, Larouze B, Diop B, Sow M, London WT, Blumberg BS: Epidemiology of hepatitis B virus infection in the rural community of tip, Senegal. Am J Epidemiol 1987; 125:140-149.
16. Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA: Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 1984; 19:521-525.
17. Hoofnagle JH: Serologic markers of hepatitis B virus infection. Annu Rev Med 1981; 32:1-11.
18. McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, et al: Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103:590-594.
19. Draelos M, Morgan T, Schifman RB, Sampliner RE: Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. JAMA 1987; 258:1193-1195.
20. Herck KV, Damme PV: Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001; 63:1-7.
21. Chang TT, Young KC, Yang YJ, Lai KA, Wu HL, Wu MH, et al: Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver 1996; 16:201-206.
22. Parkinson AJ, McMahon BJ, Hall D, Ritter D, Fitzgerald MA: Comparison of enzyme immunoassay with radioimmunoassay for detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B. J Med Virol 1990; 30:253-257.
23. Kroes ACM, Quint WGV, Heijtink RA: Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. J Med Virol 1991; 35:96-100.
24. Wu JS, Tam KM: Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone. J Formosan Med Assoc 1988; 87:944-947.
25. Silva AE, Mcmahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM: Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis 1998; 26:895-889.